Toll Free: 1-888-928-9744
Published: Oct, 2016 | Pages:
32 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
SciFluor Life Sciences, LLC - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'SciFluor Life Sciences, LLC - Product Pipeline Review - 2016', provides an overview of the SciFluor Life Sciences, LLC's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by SciFluor Life Sciences, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of SciFluor Life Sciences, LLC - The report provides overview of SciFluor Life Sciences, LLC including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses SciFluor Life Sciences, LLC's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features SciFluor Life Sciences, LLC's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate SciFluor Life Sciences, LLC's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for SciFluor Life Sciences, LLC - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding SciFluor Life Sciences, LLC's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 SciFluor Life Sciences, LLC Snapshot 5 SciFluor Life Sciences, LLC Overview 5 Key Facts 5 SciFluor Life Sciences, LLC - Research and Development Overview 6 Key Therapeutic Areas 6 SciFluor Life Sciences, LLC - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 SciFluor Life Sciences, LLC - Pipeline Products Glance 10 SciFluor Life Sciences, LLC - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 SciFluor Life Sciences, LLC - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 SciFluor Life Sciences, LLC - Drug Profiles 13 SF-0034 - Drug Profile 13 Product Description 13 Mechanism Of Action 13 R&D Progress 13 SF-0166 - Drug Profile 15 Product Description 15 Mechanism Of Action 15 R&D Progress 15 Small Molecule for Dyskinesia - Drug Profile 16 Product Description 16 Mechanism Of Action 16 R&D Progress 16 Small Molecule for Fibrosis - Drug Profile 17 Product Description 17 Mechanism Of Action 17 R&D Progress 17 Small Molecule for Fungal Infections - Drug Profile 18 Product Description 18 Mechanism Of Action 18 R&D Progress 18 Small Molecule for Infectious Diseases - Drug Profile 19 Product Description 19 Mechanism Of Action 19 R&D Progress 19 Small Molecule for Inflammatory Diseases - Drug Profile 20 Product Description 20 Mechanism Of Action 20 R&D Progress 20 Small Molecule for Neuroinflammation - Drug Profile 21 Product Description 21 Mechanism Of Action 21 R&D Progress 21 Small Molecule for Oncology - Drug Profile 22 Product Description 22 Mechanism Of Action 22 R&D Progress 22 Small Molecule for Pain - Drug Profile 23 Product Description 23 Mechanism Of Action 23 R&D Progress 23 Small Molecule for Spasticity - Drug Profile 24 Product Description 24 Mechanism Of Action 24 R&D Progress 24 SciFluor Life Sciences, LLC - Pipeline Analysis 25 SciFluor Life Sciences, LLC - Pipeline Products by Target 25 SciFluor Life Sciences, LLC - Pipeline Products by Route of Administration 26 SciFluor Life Sciences, LLC - Pipeline Products by Molecule Type 27 SciFluor Life Sciences, LLC - Pipeline Products by Mechanism of Action 28 SciFluor Life Sciences, LLC - Dormant Projects 29 SciFluor Life Sciences, LLC - Locations And Subsidiaries 30 Head Office 30 Appendix 31 Methodology 31 Coverage 31 Secondary Research 31 Primary Research 31 Expert Panel Validation 31 Contact Us 31 Disclaimer 32
List of Tables SciFluor Life Sciences, LLC, Key Facts 5 SciFluor Life Sciences, LLC - Pipeline by Indication, 2016 7 SciFluor Life Sciences, LLC - Pipeline by Stage of Development, 2016 8 SciFluor Life Sciences, LLC - Monotherapy Products in Pipeline, 2016 9 SciFluor Life Sciences, LLC - Phase II, 2016 10 SciFluor Life Sciences, LLC - Preclinical, 2016 11 SciFluor Life Sciences, LLC - Discovery, 2016 12 SciFluor Life Sciences, LLC - Pipeline by Target, 2016 25 SciFluor Life Sciences, LLC - Pipeline by Route of Administration, 2016 26 SciFluor Life Sciences, LLC - Pipeline by Molecule Type, 2016 27 SciFluor Life Sciences, LLC - Pipeline Products by Mechanism of Action, 2016 28 SciFluor Life Sciences, LLC - Dormant Developmental Projects,2016 29
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.